InsiderTrades

Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.

Accepted 2023-04-07 00:00:00 ET · period of report 2023-03-28 · accession 0001415889-23-006365 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-04-07 2023-03-28 CAPR Avat Xavier FORMER Chief BUSINESS Off S - Sale+OE $4.06 -3,000 0 -100% -$12.2K
D 2023-04-07 2023-04-05 CAPR Avat Xavier FORMER Chief BUSINESS Off M - OptEx $3.46 +84.8K 84.8K New +$293.4K
D 2023-04-07 2023-04-05 CAPR Avat Xavier FORMER Chief BUSINESS Off F - Tax $4.19 -70.0K 14.8K -83% -$293.4K
D 2023-04-07 2023-04-05 CAPR Avat Xavier FORMER Chief BUSINESS Off M - OptEx $0.00 -84.8K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-28 S D 3,000 $4.06 0 D — —
2 Common Common Stock 2023-04-05 M A 84,791 $3.46 84,791 D — —
3 Common Common Stock 2023-04-05 F D 70,019 $4.19 14,772 D — — (F1) Represents a "net exercise" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on April 5, 2023 of $4.19.
4 Derivative Stock Option (Right to Buy) 2023-04-05 M D 84,791 $0.00 0 D $3.46 · — to 2023-07-06 84,791 Common Stock (F2) The shares vested 1/48th of the first day of each month, commencing June 1, 2022. (F3) The option expires 90 days following the termination of Mr. Avat's employment with the Company. Mr. Avat's employment terminated on April 7, 2023. While the box indicating that Mr. Avat is no longer subject to Section 16 has been checked, Mr. Avat remains subject to Section 16 through such date.